HOME >> BIOLOGY >> NEWS
Food safety: French discovery explains how Listeria penetrates the body, and may suggest new drug delivery strategies

d.

These results, the culmination of a long-term project, illustrate how apparently reductionist approaches may help generate highly relevant animal models

Transgenic mice used in the French study are likely to assist scientists in better understanding a range of oral infection events. In addition, the Science findings set the stage for new studies of the body's immunological response to infection.

A March 2001 consumer advisory, issued by the U.S. Food and Drug Administration (FDA), notes that perishable items that are pre-cooked or ready-to-eat should be consumed as quickly as possible to minimize the risk of Listeria infection. The advisory also recommends cleaning refrigerators regularly and using a thermometer to maintain foods at 40 degrees Fahrenheit or colder. Further, the FDA suggests that pregnant women, older adults, and those with weakened immune systems should avoid certain foods--such as hot dogs and luncheon meats, unless they are reheated until steaming hot; as well as certain soft cheeses, refrigerated pates or meat spreads, or refrigerated smoked seafood, unless contained in a cooked dish.

The Science paper was prepared at the Pasteur Institute by Pascale Cossart's team (Unit des Interactions Bacteries Cellules), and Charles Babinet 's Unit de Biologie du Dveloppement, URA CNRS; together with Jean Lefort of Unit de Pharmacologie Cellulaire; Michael Huerre of Unit d'Histopathologie; and Pierre Gounon of Station Centrale de Microscopie Electronique.


'"/>

Contact: Ginger Pinholster
gpinhols@aaas.org
202-326-6421
American Association for the Advancement of Science
31-May-2001


Page: 1 2 3 4

Related biology news :

1. Bones from French cave show Neanderthals, Cro-Magnon hunted same prey
2. Fire on French Riviera
3. Smaller food portions may explain the French paradox of rich foods and a svelte population
4. ESA providing Kyoto estimates of French Guianas tropical forests
5. Researchers develop white wine with cholesterol-lowering benefits, discover Israeli wines healthier than French wines
6. Beyond the French paradox
7. Study seems to show why French suffer less heart disease, cancer
8. The Reason The French Have Low Levels Of Heart Disease
9. New Technology Turns French Fry Oil Into Diesel Fuel
10. French Researchers Breed Flightless Ladybirds As Pest-Killers
11. Very Fruitful Collaboration Between French And German Scientists Yields Unusual Insights Into The Structure Of Membrane Proteins

Post Your Comments:
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "Global Facial Recognition ... http://photos.prnewswire.com/prnh/20130307/600769 ... identification of individuals. Facial recognition system measures the ... nose, jaw edges, mouth, and the distance between ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has ... in India 2015-2019" report to their offering. ... this market is the adoption of multimodal biometric ... characteristic of an individual for verification and identification ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/17/2014)... 2014 Ipsen Biopharmaceuticals, Inc., an ... IPSEY), today announced that Somatuline® Depot® ... was approved by the U.S. Food and Drug ... tumors (GEP-NETs) in adult patients with unresectable, well ... to improve progression-free survival (PFS). , “The approval ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/17/2014)... Calif. , Dec. 17, 2014 ... a Phase 2 study evaluating the investigational oral ... of patients with severe, chronic itch who are ... of care, including topical steroids and antihistamines. ... change in Visual Analog Scale (VAS) itch score ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
Cached News: